VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VentriPoint Diagnostics Ltd. has successfully completed the second tranche of its non-brokered private placement, raising a total of $1,125,000. This round saw significant participation from insiders and associates, contributing 38% of the total raised funds. The company has also secured an extension for the offering until July 27, 2024, with debentures convertible into common shares at a set price and interest payable in cash or shares.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.